VIEW SELECTED LIBRARY MEDIA

Original_edited.jpg

Name of Media:

Cost-minimisation analysis of sivelestat for acute lung injury associated with systemic inflammatory response syndrome

Author(s):

Naoki Aikawa, Seitaro Fujishima, Makoto Kobayashi, Shozo Matsuoka and Taira Abiru

Publisher or Source:

Pharmacoeconomics

Type of Media:

Medical Journal

Media Originally for:

Critical Care Physicians

Country of Origin:

Japan

Primary Focus of Media:

Pre-Use of PICS Designation

COVID-19 Related:

No

Description:

Objectives: To conduct a cost-minimisation analysis of sivelestat sodium hydrate treatment for patients in the intensive care unit (ICU) with acute lung injury (ALI) associated with systemic inflammatory response syndrome (SIRS) caused by infection.

Design: The analysis was performed based on data from a phase III randomised, multicentre, double-blind, controlled clinical study of up to 14 days treatment with sivelestat, in which the effect of intravenous sivelestat at a high dose (0.20 mg/kg/h; the sivelestat group) was compared with that at a low dose (0.004 mg/kg/h, effectively a placebo; the control group).

Patients: Patients with ALI associated with SIRS caused by infection, who began their treatment under mechanical ventilation management in the ICU.

To view the attached Video media file, Click Icon:

PostICU, Inc's library staff reviewed this copyrighted material contained in the library and reasonably believes that its inclusion in our library complies with the "Fair Use Doctrine" because: (1) our library's is for nonprofit and educational purposes; (2) the nature of the copyrighted work is related to our mission; (3) the amount and substantiality of the portion used in relation to the copyrighted work as a whole is fair and reasonable; and (4) the potential market for or value of the copyrighted work will if impacted, should be enhanced, by its presence in our library.